Literature DB >> 19126134

Hemithyroidectomy for benign thyroid disease: who needs follow-up for hypothyroidism?

R Wormald1, P Sheahan, S Rowley, H Rizkalla, M Toner, C Timon.   

Abstract

OBJECTIVE: To identify the incidence and possible risk factors for the development of hypothyroidism following hemithyroidectomy and to determine a simple protocol for the post-op monitoring of thyroid function.
DESIGN: Prospective study.
SETTING: Tertiary Referral Centre. PATIENTS: Eighty-two consecutive patients who underwent hemi-thyroidectomy between May 2003 and May 2005 were included. The clinical and pathological factors were obtained and statistically analysed.
RESULTS: Eighteen per cent of patients became hypothyroid post-operatively. Multivariate analysis demonstrated that risk factors for hypothyroidism following hemithyroidectomy included a pre-operative [TSH] >1.6 microIU/L [P = 0.008, hazard ratio (HR) 14, 95% confidence interval (CI) 2-54] and lymphocytic infiltration graded 3+ or more (P < 0.001, HR 42, 95% CI, 8-195%). There was no relationship between age, sex or weight of resected tissue and the risk of hypothyroidism.
CONCLUSION: Patients with raised pre-operative [TSH] or with lymphocytic infiltration of their thyroid specimen should undergo regular testing of thyroid function within the first year of surgery. In all other patients, thyroid function at 12 months is sufficient.

Entities:  

Mesh:

Year:  2008        PMID: 19126134     DOI: 10.1111/j.1749-4486.2008.01794.x

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  19 in total

1.  Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.

Authors:  Song Jae Lee; Chang Myeon Song; Yong Bae Ji; Yun Young Choi; Young Seok Sohn; Jung Hwan Park; Dong Sun Kim; Kyung Tae
Journal:  Langenbecks Arch Surg       Date:  2021-05-10       Impact factor: 3.445

2.  Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis.

Authors:  Zhe Li; Yuxuan Qiu; Yuan Fei; Zhichao Xing; Jingqiang Zhu; Anping Su
Journal:  Endocrine       Date:  2020-07-07       Impact factor: 3.633

Review 3.  Hormone replacement after thyroid and parathyroid surgery.

Authors:  Andreas Schäffler
Journal:  Dtsch Arztebl Int       Date:  2010-11-26       Impact factor: 5.594

4.  Radiofrequency ablation of benign symptomatic thyroid nodules: prospective safety and efficacy study.

Authors:  M Umit Ugurlu; Kivilcim Uprak; Ihsan N Akpinar; Wafi Attaallah; Cumhur Yegen; Bahadir M Gulluoglu
Journal:  World J Surg       Date:  2015-04       Impact factor: 3.352

5.  Thyroid hormone replacement in women of reproductive age: is surgeon knowledge related to operative volume?

Authors:  Megan R Haymart; Max A Cayo; Herbert Chen
Journal:  Thyroid       Date:  2010-06       Impact factor: 6.568

6.  Thyroid hormone replacement after thyroid lobectomy.

Authors:  Samantha J Stoll; Susan C Pitt; Jing Liu; Sarah Schaefer; Rebecca S Sippel; Herbert Chen
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982

7.  Hypothyroidism after hemithyroidectomy.

Authors:  Meena Said; Vicki Chiu; Philip I Haigh
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

8.  Risk Factors that Predict Levothyroxine Medication after Thyroid Lobectomy.

Authors:  H S Song; C J Kim; S Lee; J S Bae; C K Jung; J Jang
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

9.  Hypothyroidism, new nodule formation and increase in nodule size in patients who have undergone hemithyroidectomy.

Authors:  Sibel Ertek; Reyhan Ünlü Ersoy; Cüneyd Anıl; Ozgür Demir; Murat Faik Erdoğan; Sevim Güllü; Dilek Berker; Kamile Gül; Uğur Unlütürk; Gürbüz Erdoğan
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

10.  Comparison of the Efficacy of Three Different Methods of Explaining the Surgical Procedure of Hemithyroidectomy.

Authors:  Sabaretnam Mayilvaganan; Channabasappa Shivaprasad
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.